Press release
Hormone Replacement Therapy Market Set to Grow at a Robust CAGR of 6.5% Through 2030, Driven by Rising Menopausal Population and Novel Treatment Approaches | DelveInsight
Hormone Replacement Therapy - Market Insights, Competitive Landscape, and Market Forecast - 2030
DelveInsight's "Hormone Replacement Therapy - Market Insights, Competitive Landscape, and Market Forecast - 2030 [https://www.delveinsight.com/report-store/hormone-replacement-therapy-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=xpr]" report provides an in-depth understanding of the hormone replacement therapy market trends, key drivers, emerging technologies, and competitive landscape across global regions. The global hormone replacement therapy market is poised for substantial expansion, with projections indicating a steady CAGR of 6.5% from 2024 to 2030. This growth trajectory reflects the increasing prevalence of hormonal disorders worldwide, coupled with an aging population and significant advancements in therapeutic options addressing various endocrine conditions across all major markets.
North America currently dominates the hormone replacement therapy treatment landscape and is expected to maintain this leadership position throughout the forecast period. This regional prominence is attributed to several factors, including the high prevalence of hormonal disorders, advanced healthcare infrastructure, and favorable reimbursement policies.
Download the Hormone Replacement Therapy Market Forecast Report to understand which factors are driving the hormone replacement therapy market @ Hormone Replacement Therapy Market Trends [https://www.delveinsight.com/sample-request/hormone-replacement-therapy-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=xpr].
The report segments the hormone replacement therapy market by therapy type, indication, route of administration, and geography. The hormone replacement therapy market by therapy type encompasses Estrogen Hormone Replacement, Growth Hormone Replacement, Thyroid Hormone Replacement, Testosterone Hormone Replacement, and other specialized hormone therapies. Among these segments, treatments targeting menopausal symptoms currently dominate the market, driven by the substantial demographic of women experiencing menopause globally. Furthermore, the male hypogonadism therapy market is also experiencing significant growth, with prevalence rates reported between 10 and 55% in patients with specific underlying conditions.
According to the hormone replacement therapy epidemiological data, the worldwide average age for menopause onset hovers around 50 years, with women at this age experiencing significant decreases in estrogen and progesterone production, triggering various symptoms that necessitate hormonal intervention. The World Health Organization reported that in 2021, women aged 50 and over constituted approximately 26% of the female global population, representing a substantial patient pool requiring management of menopausal symptoms such as vasomotor symptoms (VMS), commonly known as hot flashes and night sweats.
Discover evolving trends in the hormone replacement therapy patient pool forecasts @ Hormone Replacement Therapy Epidemiological Analysis [https://www.delveinsight.com/sample-request/hormone-replacement-therapy-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=xpr].
The competitive landscape [https://www.delveinsight.com/sample-request/hormone-replacement-therapy-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=xpr] includes big pharmaceutical companies and specialized players actively developing innovative hormone replacement therapy solutions. Key market participants include Abbott (NYSE: ABT), Novartis AG (SIX Swiss Exchange: NOVN), Pfizer Inc. (NYSE: PFE), Merck KGaA (NYSE: MRK), Bayer AG (NYSE: BAYN), Halozyme Therapeutics (NASDAQ: HALO), Eli Lilly and Company (NYSE: LLY), Viatris Inc. (NASDAQ: VTRS), F. Hoffman-La Roche (OTC: RHHBY), Novo Nordisk A/S (NYSE: NVO), Amgen Inc. (NASDAQ: AMGN), AbbVie Inc. (NYSE: ABBV), Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA), Dr. Reddy's Laboratories Ltd. (NSE: DRREDDY), Ascendis Pharma (NASDAQ: ASND), Vista Pharma, Inc. (BSE: 524711), Clarus Therapeutics, Inc. (NASDAQ: CRXT), Gedeon Richter Plc (Budapest Stock Exchange: RICHTER), Endo International plc (OTCQX: NDOI) and several others.
These companies are engaged in extensive research and development activities, strategic collaborations, and drug development for hormone replacement therapy, strengthening their market positions and addressing unmet medical needs.
Recent therapeutic advancements have substantially transformed the hormone replacement therapy landscape. A milestone development came in May 2023 when Astellas Pharma received FDA approval for VEOZAH, a treatment for moderate to severe VMS associated with menopause. This approval represents a significant innovation as a selective neurokinin 3 (NK3) receptor antagonist that addresses menopausal symptoms through a unique mechanism of action.
In June 2022, Halozyme Therapeutics announced the commercial launch of TLANDO (testosterone undecanoate), an oral treatment for testosterone replacement therapy in adult males with conditions associated with endogenous testosterone deficiency. Other notable developments include Pfizer's relaunch of DUAVEE in June 2023 following a voluntary recall, now featuring improved packaging.
Additionally, in February 2025, the FDA announced significant labeling changes for all testosterone products, removing the boxed warning about increased risk of serious cardiovascular events-such as heart attack and stroke-that had been required since 2014, after the TRAVERSE trial demonstrated no increased incidence of major adverse cardiovascular events among men with hypogonadism and preexisting or high cardiovascular risk who received testosterone therapy compared to placebo.
Discover evolving trends in the hormone replacement therapy treatment landscape @ Hormone Replacement Therapy Recent Developments [https://www.delveinsight.com/sample-request/hormone-replacement-therapy-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=xpr].
Despite robust growth projections, the HRT market faces challenges, including concerns regarding potential side effects of long-term hormone therapy use, particularly regarding liver function with some newer treatments like VEOZAH, which carries a Boxed Warning for risks of hepatotoxicity. Additionally, the complex regulatory approval process for new hormone therapies and varying reimbursement scenarios across different regions present obstacles to market expansion.
Looking ahead, the hormone replacement therapy market is expected to benefit from the introduction of innovative hormone delivery systems, personalized treatment approaches based on genetic profiling, and increased awareness about hormonal health management across all age groups. The development of bioidentical hormones and hormone therapies with improved safety profiles will likely reshape treatment paradigms and further drive market growth through 2030, creating significant opportunities for stakeholders across the hormone disorder treatment market.
Table of Contents
1. Hormone Replacement Therapy Market Report Introduction
2. Hormone Replacement Therapy Market Executive Summary
3. Hormone Replacement Therapy Competitive Landscape
4. Regulatory Analysis
5. Hormone Replacement Therapy Market Key Factors Analysis
6. Hormone Replacement Therapy Market Porter's Five Forces Analysis
7. Hormone Replacement Therapy Market Assessment
8. Hormone Replacement Therapy Market Company and Product Profiles
9. KOL Views
10. Project Approach
11. About DelveInsight
12. Disclaimer & Contact Us
About DelveInsight
DelveInsight is a leading market research and consulting firm specializing in disease-specific insights and therapeutic market analysis. Their reports integrate real-world data, clinical trial findings, and expert interviews to deliver comprehensive industry intelligence.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Arpit Anand
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=hormone-replacement-therapy-market-set-to-grow-at-a-robust-cagr-of-65-through-2030-driven-by-rising-menopausal-population-and-novel-treatment-approaches-delveinsight]
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/consulting/due-diligence-services
Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Hormone Replacement Therapy Market Set to Grow at a Robust CAGR of 6.5% Through 2030, Driven by Rising Menopausal Population and Novel Treatment Approaches | DelveInsight here
News-ID: 4214640 • Views: …
More Releases from ABNewswire
New YA Adventure "Milly and the Shawl of Athena" Transports Young Readers into a …
A gripping new teen and adventure novel has hit the shelves. Milly and the Shawl of Athena by J P Allen is a genre-defying novel which combines ancient mythology, gaming culture, and heart-wrenching family drama to produce an addictive adventure.
Set in a decade and inspired by the author's love of history, mythology, fiction, and computer games, this first in the planned series features twelve-year-old Milly Martin, whose ordinary life is…
Hudkins Publishing Music Launches Three Volumes of Background Music for Commerci …
Now they are available for every business.
KINGMAN, AZ - October 30, 2025 - Hudkins Publishing Music proudly announces the release of three new instrumental playlists explicitly designed for commercial use in cafes, offices, spas, restaurants, hotels, and creative studios. The new series-Hudkins Background Music Volumes 1-3-offers businesses royalty-free soundtracks that elevate atmosphere, encourage customer relaxation, and improve employee focus.
Each collection features 30 professionally produced instrumental tracks, available in both WAV…
Book Now the Emerging Gospel Artist "Jacqueline L. Jenkins" debuts new single "A …
BIOGRAPHY
Jacqueline L. Jenkins is an emerging gospel artist celebrated for her heartfelt lyrics and soulful vocals that blend traditional gospel spirit with contemporary rhythms. She first gained recognition with her debut single, "Thank You," which resonated deeply with listeners through its message of gratitude and faith. In 2024, Jacqueline released the Thank You - EP, featuring standout tracks such as "Going Home," a poignant tribute to her late mother, and…
Why More People Are Choosing Mobile Hair and Beauty Services Through DashStylist …
People are seeking a means of making their lives easier in the hectic world we all live in. Mobile beauty and hair services are one of the trends that are on the rise. These services help save time and efforts as the salon experience has been delivered to the home of the customer. Customers do not have to drive to a salon, wait until their turn comes and then drive…
More Releases for Hormone
Surge In Hormone Imbalance Disorders Fuels Growth Of Hormone Therapy Market Emer …
Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.
What Is the Expected CAGR for the Hormone Therapy Market Through 2025?
The size of the hormone therapy market has experienced significant growth in the past few years. It is expected to increase from $19.7 billion in 2024 to $21.1 billion in 2025, at a compound annual growth rate (CAGR) of 7.1%. The growth…
Parathyroid Hormone Market Overview: How Parathyroid Hormone Affects Health & Cl …
Parathyroid Hormone Market is predicted to grow at a CAGR 3.4% during the forecast period (2024-2031).
Parathyroid Hormone Market Report by DataM Intelligence delivers deep insights and analysis into the latest market trends, growth opportunities, and emerging challenges. Designed to help businesses make smarter, faster decisions, our reports combine both data-driven analysis and expert perspectives. At DataM Intelligence, we're committed to turning complex market landscapes into clear, actionable strategies so…
Estrogen Hormone Replacement: A Vital Segment Driving Growth in the Hormone Repl …
The Hormone Replacement Therapy (HRT) market is experiencing renewed interest, driven by an aging population and a growing understanding of hormonal health. Within this market, the estrogen hormone replacement segment stands out as a high-opportunity area, offering relief from menopausal symptoms and addressing various health concerns.
Market Dynamics and Growth Drivers
Estrogen HRT plays a crucial role in managing menopausal symptoms, such as hot flashes, night sweats, and vaginal dryness. Beyond symptom…
Klinefelter Syndrome Hormone Therapy Market - Balancing Hormones, Unleashing Pot …
Newark, New Castle, USA: The "Klinefelter Syndrome Hormone Therapy Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
Klinefelter Syndrome Hormone Therapy Market: https://www.growthplusreports.com/report/klinefelter-syndrome-hormone-therapy-market/8775
This latest report researches the…
Human Growth Hormone Market - Elevating Lives, Amplifying Growth: Innovations in …
Newark, New Castle, USA - new report, titled Human Growth Hormone Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Human Growth Hormone market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Human Growth Hormone market. The report offers an overview of…
Hormone Replacement Therapy Market Report- Segment by Application Menopause, Hyp …
The Hormone Replacement Therapy Market research report presents an intensive and coordinated exploration of the current circumstance, market key elements, Hormone Replacement Therapy Market methodologies, and central participants' development in the business. The investigation helps controllers and corporate leaders in developing cost-effective decisions. Hormone Replacement Therapy Market provides an evenhanded and extensive assessment of existing examples, factors, obstacles, limits, headway, possibilities/quick development areas that will help partners create business plans…
